David Raben sold $302K of Bicara Therapeutics (BCAX)

Executed Mar 4, disclosed Mar 5, 1 day later.

Value, as filed

$302K

16,300 sh × $18.52

Executed

Mar 4

the trade date, as filed

Disclosed

Mar 5

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

David Raben Chief Medical Officer profile →

David Raben (Chief Medical Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $406K of BCAX (22,000 sh × $18.45, as filed), executed Oct 9 2025.

The name

BCAX

Bicara Therapeutics Inc. BCAX · Healthcare · 40 filings in 24 months ticker →

Healthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David Raben in BCAX

BCAXSALE Bicara Therapeutics Inc. $126K
5,500 sh × $22.88
Exec Apr 27
Filed Apr 28 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $104K
5,500 sh × $18.95
Exec Mar 25
Filed Mar 26 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $101K
5,500 sh × $18.45
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $406K
22,000 sh × $18.45
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET